Articles tagged with Regenerative Medicine
In chronic damage, new cholesterol production determines the efficiency of repair, with nerve cells contributing to replenishing myelin-forming cells. Treatment with a cholesterol-enriched diet enhances oligodendrocyte progenitor cell proliferation.
Scientists from the University of Johannesburg found that shining two lasers on adult stem cells accelerates their transformation into different types of cells. The consecutive irradiation increases proliferation and differentiation under laboratory conditions, paving the way for potential therapies to repair damaged tissues.
A recent study highlights the negative effects of misinformation on stem cell therapies for COVID-19, including exaggerated claims and unregulated sales. The researchers advocate for increased enforcement of laws and regulations to protect patients and promote responsible science communication.
A study published in the Journal of Cell Biology found that skin stem cell motility is crucial for wound healing and skin regeneration. The researchers discovered that a specific molecule, EGFR, drives skin stem cell movement and coordinates the production of collagen COL17A1.
A new study by University of Pennsylvania researchers uses human gingiva-derived mesenchymal stem cells to guide nerve growth and regeneration, achieving similar results as traditional autograft procedures. The approach has potential for treating larger nerve gaps, including those resulting from oral cancer surgery.
A subpopulation of mesenchymal stem cells expressing CD73 has been identified as crucial for bone regeneration, displaying enhanced proliferation and differentiation capabilities. This subgroup promotes fracture healing by forming new cartilage and bone cells, contributing to the remodeling process.
The University of California, Riverside has received a $5 million grant from the California Institute for Regenerative Medicine to train young scientists and physicians in stem cell research. The program, named TRANSCEND, will provide training in broad areas of stem cell biology and regenerative medicine.
A team of researchers has identified a cellular mechanism that enables embryonic stem cells to maintain their state as stem cells. The study, published in Cell Reports, reveals the genetic ingredients required for ESCs to decide whether to divide or differentiate.
A new ex vivo drug delivery system has been shown to keep MSCs viable longer and reprogram the peripheral immune response toward organ repair. The study's results suggest that SBI-101 can impact a peripheral immune response that can be transmitted to local tissue damage in vital organs, including the kidney.
The Lundquist Institute has received a prestigious CIRM Scholar Research Training Award to support its PhD students, postdoctoral fellows, and clinical fellows in stem cell biology and regenerative medicine. The grant will enable the institute to create a stem-cell focused program, recruit researchers, and retain talent in the field.
Researchers link repeated injury to airway stem cells with chronic lung disease, suggesting that biological aging of these cells may contribute to the development of this condition. The study found that injury caused activation of a subset of stem cells, leading to their premature aging and loss of functional capacity.
A study found that treating wounds with mesenchymal stromal cell secretions significantly reduced MRSA viability and stimulated the surrounding skin cells to build a defense. The treatment has potential as an alternative to antibiotics, reducing antibiotic resistance in both veterinary and human medicine.
Researchers developed lab-grown cochlear organoids to screen FDA-approved drugs for hair cell-inducing properties. The study identified Regorafenib as a potent stimulator of hair cell formation, even regenerating lost cells in mouse tissues.
A multi-center study found micro-fragmented adipose tissue injections to be highly effective in reducing knee pain, improving function, and enhancing quality of life. Positive effects were observed for up to 12 months, with notable differences in efficacy among demographics.
A pilot study found that a single injection of leukocyte-rich platelet-rich plasma (PRP) significantly improved functional mobility, pain, and quality of life in patients with knee osteoarthritis. The study supports the use of this combined approach to evaluate emerging biological therapies for musculoskeletal disorders.
Researchers from Terasaki Institute for Biomedical Innovation develop methods to enhance mechanical properties of hydrogels, including toughness, stretchiness, and adhesive strength. By introducing dopamine and alkaline conditions, they create gel-like materials with improved biocompatibility and regenerative capabilities.
Researchers have created brain organoids from people with 16p11.2 genomic variations, which exhibit differences in brain size seen in individuals with autism spectrum disorder. The study revealed new information about molecular mechanisms that malfunction when this region is disrupted, providing opportunities for therapeutic intervention.
Researchers at UCLA developed brain organoids that mimic human brain structure and function, allowing for the study of neurological disorders like Rett syndrome. The organoids showed organized waves of activity similar to those found in living brains and responded to treatment with an experimental drug.
A new study from Monash University has identified RNA released from damaged cells as a signal to initiate repair in the nervous system. The research found that blocking or enhancing this recruitment of immature neurons halted or sped up neural circuit recovery, demonstrating their power in boosting neural repair.
A USC-led study has mapped the developmental blueprint of human kidneys, shedding light on how cells interact to form filtering units. The research provides a foundation for creating synthetic mini kidneys and could lead to new treatments for kidney diseases.
Researchers discovered that fetal membranes can heal after injury through the action of cells called myofibroblasts and protein Cx43. This finding holds promise for reducing the risk of birth complications from preterm prelabour rupture of the membranes, a leading cause of early infant death.
A new clinical study reveals that treatment with mesenchymal stromal cells reduces inflammation in patients with chronic obstructive pulmonary disease (COPD). The study provides insights into the therapeutic potential of MSCs as a novel treatment for COPD, which is a leading cause of morbidity and mortality worldwide.
Researchers used autologous adipose micrografts to treat tendon injuries in sheep, achieving similar diameter and hardness to healthy tendons within two months. The study suggests a safe, reliable, and relatively fast way to promote tendon healing, with potential for human treatment.
Scientists at University of California San Diego School of Medicine have developed a method to keep cultured hematopoietic stem cells healthy, positive news for patients seeking stem cell transplants. The findings also hint at a new way to ward off aging by super-activating the heat shock pathway.
Researchers developed gel drops from four amino acid peptides that support cell growth and induce blood vessel formation. The microgels were successfully used to grow endothelial cells on their surfaces, which then extended into tubular blood vessels.
A study confirmed the safety of a novel stem cell therapy for knee pain caused by osteoarthritis. The treatment, which involves transplanting patient's own mesenchymal stem cells into the affected knee, showed no serious side effects over five years.
The Wake Forest Institute for Regenerative Medicine and local partners receive an NSF grant to develop a regional regenerative medicine educational network. The project aims to address the workforce needs of the rapidly evolving field, focusing on skilled technician development in biomanufacturing.
Researchers from USC Stem Cell discovered a latent regenerative potential in the inner ear's sensory cells. They found that epigenetic modifications regulate hair cell development and identified a key histone decoration, H3K4me1, that keeps supporting cells primed for transdifferentiation.
A national survey reveals a pronounced lack of needed skills in the regenerative medicine biomanufacturing workforce, highlighting key findings and recommendations to address this gap. The study suggests five strategies for developing the workforce ecosystem, including faculty development opportunities, work-based learning, and policy ...
Researchers discovered a code in the liver epigenome that promotes regeneration, enabling pro-regenerative genes to activate when signaled. This finding has potential to inform regenerative medicine for non-regenerative organs like lungs and hearts.
Researchers at Cedars-Sinai are conducting a clinical trial to transplant neural progenitor cells into the brains of ALS patients to slow disease progression. The cells have been genetically reprogrammed to express GDNF, which may help keep motor neurons healthy and extend survival.
Scientists at USC have created rudimentary kidney structures, known as organoids, that resemble the collecting duct system. These organoids can be used to study kidney disease and test potential therapeutic drugs.
Experts call for global regulation to prevent unproven stem cell treatments from putting patients' lives at risk. The authors propose establishing an advisory committee on regenerative medicine and promoting harmonization among regulatory standards.
A clinical trial found that non-altered stem cells from umbilical cord connective tissue increased the survival of critically ill COVID-19 patients by 2.5 times. The treatment also showed a fourfold increase in survival for patients with chronic health conditions.
Researchers develop non-invasive tool to assess oral keratinocyte quality, correlating cell motion speed with regenerative capacity and proliferation potential. The cells/colony motion index makes a reliable quality control tool for engineered cells used in regenerative medicine.
Researchers found that autologous bone marrow stromal stem cells can lower blood glucose levels and reduce medication doses in non-obese Type 2 diabetes patients with a short disease duration. The study's results are promising for the potential treatment of this chronic disease.
Researchers discovered differences in molecular signaling that promote regeneration in axolotls, while blocking it in adult mice. This finding brings science closer to developing regenerative medicine therapies for humans.
Researchers have developed a novel strategy to treat, prevent, and possibly reverse liver damages by exploiting small extracellular vesicles derived from interferon-γ pre-conditioned MSCs. The approach has shown promising results in reducing inflammation and fibrosis in a mouse model of cirrhosis.
Researchers developed an acellular product, PEP, derived from platelets that heals ischemic wounds by delivering healing messages to cells. The study demonstrates restoration of skin integrity and function in preclinical animal models.
Researchers assessed the effectiveness of treating preterm infants with umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) directly into their tracheas. Early results showed signs of improvement for the most immature infants included in the trial, but further study is needed to solidify therapeutic benefits.
Researchers found that applying fat grafts enriched with adipose-derived stem cells improved fat retention in LoS patients. The study suggested a safe and feasible alternative to conventional treatment methods for correcting facial atrophy.
A new stem cell therapy has induced regeneration of blood vessels surrounding non-healing diabetic foot ulcers, accelerating healing. The treatment uses adult stem cells harvested from fat tissue, demonstrating a novel cell injection therapy that can alleviate pain and infection.
Scientists have developed a novel technology combining 3-D bioelectronic systems with human neural cultures to study brain development and repair. The device can record electrical activity, manipulate neural activity using light pulses, and perform optogenetic experiments.
Scientists developed a tri-tube heart valve replacement that can regenerate and grow over time, addressing the need for long-term valve replacements in children with congenital heart disorders. The new design showed improved growth dynamics and reduced calcification compared to clinically used bioprosthetic valves.
Researchers at UPMC demonstrated that allogeneic adipose-derived stem cells (ASCs) can mitigate acute radiation syndrome, a condition known as total body irradiation. ASCs were found to improve survival rates and repair damage to the hematopoietic system in mice exposed to high levels of radiation.
Researchers investigate using a cell-signaling chemokine from cats to treat human kidney fibrosis and slow disease progression. The study suggests that intra-renal injection of CXCL12 may be a potential therapy for early kidney disease, offering new hope for millions with the condition.
A clinical trial revealed that bone marrow cell injections can lead to a reduction in brain injury after a stroke, with improvements seen in the corticospinal tract 12 months post-treatment. The study suggests a potential approach for regenerative therapies to improve brain health for millions of patients affected by stroke.
A phase I clinical trial reveals adipose-derived stem cells alleviate symptoms of lymphedema, improving upper extremity function and reducing treatment use. Patients experienced sustained benefits for up to four years after treatment.
Researchers at JAIST and RIKEN identify COOH-PLL as an effective cryoprotectant that prevents cellular damage during freezing. The team uses NMR spectroscopy to characterize the molecule's behavior, enabling the design of new polymeric cryoprotectants.
A new study introduces mRNA-LNP as a safe therapeutic intervention for liver regeneration, utilizing the same science used in COVID-19 vaccines. Researchers successfully induce rapid expansion of functional liver cells and recovery of liver function in injured livers.
A clinical trial evaluated the safety and effectiveness of two cell therapies for treating angiitis-induced critical limb ischemia, yielding satisfactory results. The study found that both therapies provided evidence for precise application under different conditions.
Researchers at Sungkyunkwan University found that stem cell-derived extracellular vesicles can reduce severe intraventricular hemorrhage-induced brain injuries in newborn rats. The neuroprotection is primarily mediated by BDNF transfer via EVs, providing a promising potential treatment for bleeding in the brain.
The 16th World Stem Cell Summit will be co-located with the 7th annual Regenerative Medicine Essentials Course, featuring joint single-track programming on stem cells, biomaterials, cell therapies, clinical trials, and regulatory matters. The event aims to accelerate regenerative medicine and deliver cures.
Researchers found that pre-treating early outgrowth cells with a chemical activator slows the development of atherosclerosis in mice. The study showed that this treatment reduced inflammation and plaque buildup in arteries, providing potential hope for treating cardiovascular diseases.
Researchers have developed a novel method to bioprint fibrocartilage, a crucial tissue in knee joints, using a hybrid tissue construct. The study demonstrates the potential of this regenerative medicine treatment for repairing damaged cartilage and restoring knee function.
A study in STEM CELLS Translational Medicine suggests that amniotic fluid stem cell-derived secretome can restore neuronal plasticity and improve cognition after an ischemic stroke. The findings offer a potential new avenue of treatment for ischemic stroke, which affects 87% of all strokes.
The UK Research and Innovation has partnered with the Japan Agency for Medical Research and Development to support eight new regenerative medicine research projects. The funding will focus on developing novel therapies for a range of disorders, including Parkinson's disease, blood disorders, and liver diseases.
Researchers have found a way to restore muscle regeneration and prevent scarring in Duchenne muscular dystrophy by correcting the content of extracellular vesicles. This novel approach uses pharmacologically corrected vesicles to deliver HDAC inhibitors directly to muscles, overcoming systemic adverse effects.
Researchers biofabricated human colorectal cancer organoids to understand how tumors grow in their natural microenvironment and respond to treatments. The study replicated native tumor tissue in a laboratory model and validated its effects on whole-body physiology, paving the way for new therapies targeting the extracellular matrix.
Researchers have developed a bioengineered scaffold using human mesenchymal stem cells and timolol, which significantly improved wound epithelialization and reduced inflammatory response in diabetic mice. The combination therapy resulted in more than a 70% increase in tissue repair compared to the control group.